okredo logo
none title certification

"Biotechnologijų projektai", MB Finance - revenue, profit

eye icon
More information

EBITDA margin (%)

unlock data icon

Register and

explore Okredo data
More information

EBIT margin (%)

unlock data icon

Register and

explore Okredo data

EBITDA margin (%)

Login to see the data

EBIT margin (%)

Login to see the data

Financial statetment report

Price: €9.90
Premium users: 1.00 credit
Indicator
Turnover (€)
Sales per employee (€)info
Profit before tax (€)
Net Profit (€)
Profit per employee (€)info
Working capital requirementinfo
Debt-to-equity ratioinfo
Total profitability (%)info
Net profitability (%)info
Equity (€)
Amounts Payable And Liabilities (€)
Non-current Assets (€)
CurrentAssets (€)
EBITDA margin (%)info
EBITDA (€)info
EBIT margin (%)info
EBIT (€)info
2020
83,739
-
1,085
889
-
0.54
0.27
29.00
1.06
49,200
13,487
3,913
58,774
2021
120,066
-
19,608
16,650
-
0.52
0.31
36.37
13.87
65,851
20,438
3,719
82,570
unlock data icon

Register and

explore Okredo data
2021
120,066
-
19,608
16,650
-
0.52
0.31
36.37
13.87
65,851
20,438
3,719
82,570
unlock data icon

Register and

explore Okredo data

2021

Turnover (€)

120,066 €Ascended43 % *

Sales per employee (€)

-

Profit before tax (€)

19,608 €Ascended1,707 % *

Net Profit (€)

16,650 €Ascended1,773 % *

Profit per employee (€)

-

Working capital requirement

0.52 Descended-3.70 % *

Debt-to-equity ratio

0.31 Ascended14.81 % *

Total profitability (%)

36.37 %Ascended25.41 % *

Net profitability (%)

13.87 %Ascended1,208.49 % *

Equity (€)

65,851 €Ascended34 % *

Amounts Payable And Liabilities (€)

20,438 €Ascended52 % *

Non-current Assets (€)

3,719 €Descended-5 % *

CurrentAssets (€)

82,570 €Ascended40 % *

*over the last year starting selected period